...
首页> 外文期刊>Infectious Diseases and Therapy >A Comprehensive Review of Meningococcal Disease Burden in India
【24h】

A Comprehensive Review of Meningococcal Disease Burden in India

机译:印度脑膜炎球菌疾病负担的全面综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

IntroductionMeningococcal disease caused by Neisseria meningitidis has a high case fatality rate. Of 12 distinct serogroups, A, B, C, W-135 (W) and Y cause the majority of infections. The meningococcal disease burden and epidemiology in India are not reliably known. Hence, we performed a narrative review with a systematically conducted search to summarize information on meningococcal disease burden and epidemiology and vaccination recommendations for meningococcal disease in India.MethodsA search of Medline and Embase databases was undertaken to identify relevant publications published in the last 25?years.ResultsResults from 32 original publications, 11 of which were case reports, suggest a significant burden of meningococcal disease and related complications. Meningococcal disease is increasingly reported among adolescents and adults, and large outbreaks have been reported in this population. Meningococcal disease in India is caused almost exclusively by serogroup A; serogroups B, C, W and Y have also been documented. Meningococcal disease burden data remain unreliable because of limited disease surveillance, insufficient laboratory capacity, misdiagnosis and prevalence of extensive antibiotic use in India. Lack of access to healthcare also increases under-reporting, thus bringing the reliability of the data into question. Conjugate meningococcal vaccines are being used for disease prevention by national governments and immunization programs globally. In India, meningococcal vaccination is recommended only for certain high-risk groups, during outbreaks and for international travelers such as Hajj pilgrims and students pursuing studies abroad.ConclusionMeningococcal disease is prevalent in India but remains grossly underestimated and under-reported. Available literature largely presents outbreak data related to serogroup A disease; however, non-A serogroup disease cases have been reported. Reliable epidemiologic data are urgently needed to inform the true burden of endemic disease. Further research into the significance of meningococcal disease burden can be used to improve public health policy in India.
机译:脑膜炎脑膜炎引起的引入细胞疾病具有高病例的死亡率。 12个不同的血清组,A,B,C,W-135(W)和Y导致大多数感染。印度的脑膜炎球菌疾病和流行病学都不是可靠的。因此,我们进行了一个叙事审查,并系统地进行了叙述,总结了印度脑膜炎球菌病的脑膜炎球菌疾病和流行病学和疫苗接种建议的信息。在寻找Medline和Embase数据库中,以确定过去25岁以下发表的相关出版物从32个原始出版物,其中11个是案例报告的,提出了脑膜炎球菌疾病和相关并发症的重大负担。脑膜炎球菌疾病越来越多地报道青少年和成人,并且在这个人口中报告了大爆发。印度的脑膜炎球菌疾病几乎完全由Serogroup A引起;还记录了SeroGroups B,C,W和Y。由于有限的疾病监测,实验室能力,误诊和广义广泛抗生素使用的患病,脑膜炎球菌疾病的负荷数据仍然不可靠。缺乏对医疗保健的进入也增加了报告下,从而使数据的可靠性成为问题。共轭脑膜炎球菌疫苗用于全球各国政府和免疫计划的疾病预防。在印度,脑膜炎球菌疫苗接种仅适用于某些高风险群体,在爆发期间,以及朝觐朝圣者等国际旅行者,如海外追求出国研究。在印度普遍存在,但仍然普遍存在,但仍然被低估和欠报道。可用文献在很大程度上呈现出与血清群相关的爆发数据;但是,已经报道了非血清群体病例。迫切需要可靠的流行病学数据来告知真正的特有疾病负担。进一步研究脑膜炎球菌疾病负担的重要性可用于改善印度的公共卫生政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号